At that time, Fetzima (generic name levomilnacipran) was still under patent protection, and there was no generic version available.
The availability of generic medications depends on various factors, including the drug's patent expiration and the approval of generic manufacturers by regulatory authorities. Patents typically last for a certain number of years after the drug's initial approval, during which the manufacturer has exclusive rights to produce and sell the medication. Once the patent expires, other pharmaceutical companies can apply to produce generic versions, which are generally more affordable than the brand-name drug.
To find out the current status of Fetzima's generic availability, I recommend checking with reputable sources, such as the U.S. Food and Drug Administration (FDA) or other regulatory agencies in your country. Additionally, your healthcare provider or pharmacist can provide the most up-to-date information regarding generic versions of Fetzima and alternative treatment options for depression.